Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy.
- DOI
- 10.1016/j.jtct.2026.11.008
- Published
- 2026 Nov 8
- Container
- Transplantation and cellular therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2026.11.008,
title = {Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy.},
author = {Esquirol A and Garcia-Cadenas I and Redondo S and Garrido A and Lopez J and Oñate G and Paviglianiti A and Caballero AC and Bosch A and Muntañola A and Saavedra S and Argüello-Tomas M and Briones J and Sierra J and Martino R},
year = {2026},
journal = {Transplantation and cellular therapy},
doi = {10.1016/j.jtct.2026.11.008},
url = {https://doi.org/10.1016/j.jtct.2026.11.008}
}RIS
TY - JOUR TI - Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy. AU - Esquirol A AU - Garcia-Cadenas I AU - Redondo S AU - Garrido A AU - Lopez J AU - Oñate G AU - Paviglianiti A AU - Caballero AC AU - Bosch A AU - Muntañola A AU - Saavedra S AU - Argüello-Tomas M AU - Briones J AU - Sierra J AU - Martino R PY - 2026 JO - Transplantation and cellular therapy DO - 10.1016/j.jtct.2026.11.008 UR - https://doi.org/10.1016/j.jtct.2026.11.008 ER -
APA
A, E., I, G., S, R., A, G., J, L., G, O., A, P., AC, C., A, B., A, M., S, S., M, A., J, B., J, S., & R, M. (2026). Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.11.008
Source records
- pubmed · retrieved 2026-11-10T11:47:53.918Z